Cancer Treatment Centers of America appoints Chief Medical Officer

January 12, 2019

In his new role, Julian Schink, MD, will provide leadership and direction for CTCA clinical programs. He also will serve as a liaison between physicians and administrative leaders.“I am excited to take on this new challenge,” says Dr. Schink. “I’m thrilled to work with my talented colleagues across the enterprise and am laser-focused on the opportunities we have to expand access to innovative treatment options and compassionate care for patients across the U.S. and internationally.”

About Cancer Treatment Centers of America
Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.